(Press-News.org) Researchers at the University of California, San Diego School of Medicine have identified a previously unknown biological mechanism involved in the regulation of pancreatic islet beta cells, whose role is to produce and release insulin. The discovery suggests a new therapeutic target for treating dysfunctional beta cells and type 2 diabetes, a disease affecting more than 25 million Americans.
Writing in the April 11, 2013 issue of Cell, Jerrold M. Olefsky, MD, associate dean for scientific affairs and distinguished professor of medicine, and colleagues say a transmembrane binding protein called fractalkine, which typically mediates cell-to-cell adhesion though its receptor, CX3CR1, can also be released from cells to circulate in the blood and stimulate insulin secretion.
"Our discovery of fractalkine's role in beta cells is novel and has never been talked about in prior literature," said Olefsky. More importantly, the research highlights fractalkine's apparently vital role in normal, healthy beta cell function. In mouse models and in cultured human islets, the researchers found administering the protein stimulated insulin secretion and improved glucose tolerance, both key factors in diabetes. In contrast, fractalkine had no effect in mice or islets when the fractalkine receptor was deleted.
"Whether or not decreased fractalkine or impaired fractalkine signaling are causes of decreased beta cell function in diabetes is unknown," said Olefsky. "What we do know, without doubt, is that administration of fractalkine improves or restores insulin secretion in all of the mouse models we have examined, as well as in human islet cells."
Olefsky said fractalkine or a protein analog could prove "a potential treatment to improve insulin secretion in type 2 diabetic patients. It might also improve beta cell function or beta cell health, beyond simply increasing insulin secretion, since fractalkine prevents beta cell apoptosis (cell death) and promotes the beta cell differentiation program.
"If successfully developed, this could be an important new complement to the therapeutic arsenal we use in type 2 diabetes," Olefsky continued. "It is not likely to 'cure' diabetes, but it would certainly do a good job at providing glycemic control."
###
Co-authors of this study include Yun Sok Lee, Hidetaka Morinaga, and William Lagakos, UCSD Department of Medicine, Division of Endocrinology and Metabolism; Jane J. Kim and Ayse G. Kayali, UCSD Department of Pediatrics; Susan Taylor and Malik Keshwani, UCSD Department of Pharmacology; Guy Perkins, National Center for Microscopy and Imaging Research at UCSD; Hui Dong, UCSD Department of Medicine, Division of Gastroenterology; and Ian R. Sweet, Department of Medicine, University of Washington.
Funding came, in part, from the National Institutes of Health (grants DK-033651, DK-074868, T32-DK-007494 and DK-063491) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH (U54-HD-012303-25).
END
VIDEO:
Ph.D. Student Arvid Guterstam explains how he and his colleagues at Karolinska Institutet in Sweden can evoke the illusion of having a phantom hand in non-amputated individuals.
Click here for more information.
The sensation of having a physical body is not as self-evident as one might think. Almost everyone who has had an arm or leg amputated experiences a phantom limb: a vivid sensation that the missing limb is still present. A new study by neuroscientists at the Karolinska ...
Regulating alcohol outlet density, or the number of physical locations in which alcoholic beverages are available for purchase in a geographic area, is an effective strategy for reducing excessive alcohol consumption and associated harms. A new report from the Center on Alcohol Marketing and Youth (CAMY) at the Johns Hopkins Bloomberg School of Public Health documents how localities can address alcohol outlet density, and outlines the critical role of health departments and community coalitions in these efforts. The report, published in the journal Preventing Chronic Disease, ...
VIDEO:
The video as it appears in the JoVE article.
Click here for more information.
On April 11th JoVE (Journal of Visualized Experiments) will publish a new video article by Dr. Aydogan Ozcan demonstrating how a cell phone camera can capture images from a fluorescent microscope and flow cytometer, which will make it possible for areas with limited resources to easily run tests such as checking for contaminated water and monitoring HIV positive patients.
In the new video ...
CAMBRIDGE, Mass. (April 11, 2013) – In a surprising finding that helps explain fundamental behaviors of normal and diseased cells, Whitehead Institute scientists have discovered a set of powerful gene regulators dubbed "super-enhancers" that control cell state and identity. Healthy cells employ these super-enhancers to control genes responsible for cellular functions and developmental transitions—such as that from embryonic stem cell to nerve cell—but cancer cells are able to assemble their own insidious super-enhancers to overproduce harmful oncogenes that lead to aggressive ...
A team of researchers at the Johns Hopkins Children's Center has found that a protein long believed to have a minor role in type 2 diabetes is, in fact, a central player in the development of the condition that affects nearly 26 million people in the United States alone and counts as one of the leading causes of heart disease, stroke and kidney, eye and nerve damage.
Working with mice, the scientists discovered that a protein called EPAC2 — deemed a second-fiddle player up until now — is actually an important regulator of insulin that appears to work by nudging insulin-secreting ...
Tumor necrosis factor – normally an infection-fighting substance produced by the body– can actually heighten susceptibility to tuberculosis if its levels are too high.
University of Washington TB researchers unravel this conundrum in a report this week in Cell.
Their study shows how excess production of this disease-cell destroyer at first acts as a TB germ killer. But later the opposite occurs: too much tumor necrosis factor encourages TB pathogens to multiply in the body.
In addition to figuring out some reasons behind this back-pedaling, the scientists learned ...
A "garden variety" leaf is a broad, flat structure, but if the garden happens to be somewhere arid, it probably includes succulent plants with plump leaves full of precious water. Fat leaves did not emerge in the plant world easily. A new Brown University study published in Current Biology reports that to sustain efficient photosynthesis, they required the evolution of a fundamental remodeling of leaf vein structure: the addition of a third dimension.
Leaves, after all, are food factories complete with plumbing to transport water and sugar. The farther those veins are ...
In order to improve a simulation designed to study the evolution of the solar system through time, numerical mathematical methods have been developed at the Computing Faculty of the University of the Basque Country (UPV/EHU). Specifically, the methods proposed enable the simulation calculations to be done faster and more accurately.
The methodology developed at the UPV/EHU's Computing Faculty is a clear example of interdisciplinarity and collaboration. Indeed, mathematicians, computer scientists, physicists and astronomers have been working together on this task, and ...
Circadian rhythms keep time for all living things, from regulating when plants open their flowers to foiling people when they try to beat jet lag. Day-night cycles are controlled through ancient biological mechanisms, evolutionarily speaking, so in essence, a human has the same internal clock as a fly does.
These circadian clocks govern daily rhythms through genes that synchronize molecular pathways that promote or repress protein production, influencing a multitude of body functions. Even before waking, for example, our clock-driven metabolism turns on enzymes and transporters ...
Twelve years after a breakthrough discovery in his University of California, Berkeley, laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true.
On April 11, the pharmaceutical company Sanofi will launch the large-scale production of a partially synthetic version of artemisinin, a chemical critical to making today's front-line antimalaria drug, based on Keasling's discovery.
The drug is the first triumph of the nascent field of synthetic biology and will be, Keasling hopes, a lifesaver for the hundreds of millions of people in developing ...
